Weider modifies "virus resistance," "cancer" structure/function claims after FDA objection.
This article was originally published in The Tan Sheet
Executive Summary
WEIDER MODIFIES "VIRUS RESISTANCE," "CANCER" SUPPLEMENT CLAIMS after FDA sent a July 30 "courtesy" letter. In response to FDA's notification that the claims do not meet the structure/function claim standards established in the Dietary Supplement Health & Education Act, Weider Nutrition Group has changed its claims for the two products -- Schiff All Natural Echinacea Cold Season Formula and Schiff Phytocharged Lycopene.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning